CD44 and breast cancer: The expression levels of breast cancer stem cell markers, such as CD44 and Nanog33,43,44, as well as the expression levels of Jagged-1 and Hes1, were increased in BMP-4-treated MDA-MB-231 cells, compared to control cells (Fig. 6b–d).